Eli Lilly and Company (NYSE:LLY) Position Cut by Klingenstein Fields & Co. LP
Klingenstein Fields & Co. LP trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,564 shares of the company’s stock after selling 1,156 shares during the quarter. Eli […]